Alimentary Pharmacology & Therapeutics

Cover image for Alimentary Pharmacology & Therapeutics

April 1990

Volume 4, Issue 2

Pages 103–211

    1. The efficacy of tobramycin in the treatment of ulcerative colitis (pages 123–129)

      D. A. BURKE, A. T. R. AXON, S. A. CLAYDEN, M. F. DIXON, D. JOHNSTON and R. W. LACEY

      Version of Record online: 31 MAR 2007 | DOI: 10.1111/j.1365-2036.1990.tb00456.x

    2. Serum gastrin levels during long-term omeprazole treatment (pages 131–138)

      H. KOOP, M. KLEIN and R. ARNOLD

      Version of Record online: 31 MAR 2007 | DOI: 10.1111/j.1365-2036.1990.tb00457.x

    3. Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist (pages 139–144)

      S. GORE, I. T. GILMORE, C. G. HAIGH, S. M. BROWNLESS, H. STOCKDALE and A. I. MORRIS

      Version of Record online: 31 MAR 2007 | DOI: 10.1111/j.1365-2036.1990.tb00458.x

    4. Omepmazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to ‘standard doses’of H2-receptor antagonists (pages 145–155)

      L. LUNDELL, L. BACKMAN, P. EKSTRÖM, L.-H. ENANDER, O. FAUSA, T. LIND, H. LÖNROTH, S. SANDMARK, B. SANDZÉN, P. UNGE and I. H. WESTIN

      Version of Record online: 31 MAR 2007 | DOI: 10.1111/j.1365-2036.1990.tb00459.x

    5. The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulceration (pages 157–162)

      A. A. DUNK, U. PRABHU, A. TOBIN, C. O'MORAIN and N. A. G. MOWAT

      Version of Record online: 31 MAR 2007 | DOI: 10.1111/j.1365-2036.1990.tb00460.x

    6. The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate) (pages 163–169)

      C U. NWOKOLO, P. MISTRY and R. E. POUNDER

      Version of Record online: 31 MAR 2007 | DOI: 10.1111/j.1365-2036.1990.tb00461.x

    7. Effect of ranitidine and indomethacin on nocturnal gastric acidity in normal subjects (pages 171–176)

      R. P. WALT, T. K. DANESHMEND, P. PRICHARD and M. J. S. LANGMAN

      Version of Record online: 31 MAR 2007 | DOI: 10.1111/j.1365-2036.1990.tb00462.x

    8. Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome (pages 177–182)

      L. J. D. O'DONNELL, A. J. M. WATSON, D. CAMERON and M. J. G. FARTHING

      Version of Record online: 31 MAR 2007 | DOI: 10.1111/j.1365-2036.1990.tb00463.x

    9. Amino acid tolerance in cirrhotic patients following oral protein and amino acid loads (pages 183–200)

      M. Y. MORGAN, K. E. HAWLEY and D. STAMBUK

      Version of Record online: 31 MAR 2007 | DOI: 10.1111/j.1365-2036.1990.tb00464.x

    10. A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis (pages 201–211)

      R. F. P. QUIK, M. J. COOPER, M. GLEESON, E. HENTSCHEL, K. SCHUETZE, R. D. KINGSTON and M. MITCHELL

      Version of Record online: 31 MAR 2007 | DOI: 10.1111/j.1365-2036.1990.tb00465.x

SEARCH

SEARCH BY CITATION